{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T11:18:44Z","timestamp":1792667924322,"version":"4.5.0"},"reference-count":83,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2019,7,22]],"date-time":"2019-07-22T00:00:00Z","timestamp":1563753600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Fondazione Regionale per la Ricerca Biomedica","award":["2015-0043"],"award-info":[{"award-number":["2015-0043"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>In the 1970s\u20131980s, a striking increase in the number of disseminated human cytomegalovirus (HCMV) infections occurred in immunosuppressed patient populations. Autopsy findings documented the in vivo disseminated infection (besides fibroblasts) of epithelial cells, endothelial cells, and polymorphonuclear leukocytes. As a result, multiple diagnostic assays, such as quantification of HCMV antigenemia (pp65), viremia (infectious virus), and DNAemia (HCMV DNA) in patient blood, were developed. In vitro experiments showed that only low passage or endothelial cell-passaged clinical isolates, and not laboratory-adapted strains, could reproduce both HCMV leuko- and endothelial cell-tropism, which were found through genetic analysis to require the three viral genes UL128, UL130, and UL131 of the HCMV UL128 locus (UL128L). Products of this locus, together with gH\/gL, were shown to form the gH\/gL\/pUL128L pentamer complex (PC) required for infection of epithelial cells\/endothelial cells, whereas gH\/gL and gO form the gH\/gL\/gO trimer complex (TC) required for infection of all cell types. In 2016, following previous work, a receptor for the TC that mediates entry into fibroblasts was identified as PDGFR\u03b1, while in 2018, a receptor for the PC that mediates entry into endothelial\/epithelial cells was identified as neuropilin2 (Nrp2). Furthermore, the olfactory receptor family member OR14I1 was recently identified as a possible additional receptor for the PC in epithelial cells. Thus, current data support two models of viral entry: (i) in fibroblasts, following interaction of PDGFR\u03b1 with TC, the latter activates gB to fuse the virus envelope with the cell membrane, whereas (ii) in epithelial cells\/endothelial cells, interaction of Nrp2 (and OR14I1) with PC promotes endocytosis of virus particles, followed by gB activation by gH\/gL\/gO (or gH\/gL) and final low-pH entry into the cell.<\/jats:p>","DOI":"10.3390\/vaccines7030070","type":"journal-article","created":{"date-parts":[[2019,7,22]],"date-time":"2019-07-22T11:07:28Z","timestamp":1563793648000},"page":"70","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":94,"title":["Human Cytomegalovirus Cell Tropism and Host Cell Receptors"],"prefix":"10.3390","volume":"7","author":[{"given":"Giuseppe","family":"Gerna","sequence":"first","affiliation":[{"name":"Laboratories of Genetics, Transplantology and Cardiovascular Diseases, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2077-472X","authenticated-orcid":false,"given":"Anna","family":"Kabanova","sequence":"additional","affiliation":[{"name":"Toscana Life Sciences Foundation, 53100 Siena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7747-7622","authenticated-orcid":false,"given":"Daniele","family":"Lilleri","sequence":"additional","affiliation":[{"name":"Laboratories of Genetics, Transplantology and Cardiovascular Diseases, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,7,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1099\/0022-1317-76-4-741","article-title":"Fibroblasts, epithelial cells, endothelial cells and smooth muscle cells are major targets of human cytomegalovirus infection in lung and gastrointestinal tissues","volume":"76","author":"Sinzger","year":"1995","journal-title":"J. Gen. Virol."},{"key":"ref_2","first-page":"63","article-title":"Cytomegalovirus cell tropism","volume":"325","author":"Sinzger","year":"2008","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0065-3527(08)60073-1","article-title":"Cell types involved in replication and distribution of human cytomegalovirus","volume":"46","author":"Plachter","year":"1996","journal-title":"Adv. Virus Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.humimm.2004.02.009","article-title":"Pathogenesis of human cytomegalovirus infection and cellular targets","volume":"65","author":"Gerna","year":"2004","journal-title":"Hum. Immunol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3389\/fmicb.2014.00389","article-title":"The intimate relationship between human cytomegalovirus and the dendritic cell lineage","volume":"5","author":"Sinclair","year":"2014","journal-title":"Front. Microbiol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S0046-8177(84)80076-3","article-title":"Widespread presence of histologically occult cytomegalovirus","volume":"15","author":"Myerson","year":"1984","journal-title":"Hum. Pathol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1172\/JCI116635","article-title":"Circulating endothelial giant cells permissive for human cytomegalovirus (HCMV) are detected in disseminated HCMV infections with organ involvement","volume":"92","author":"Percivalle","year":"1993","journal-title":"J. Clin. Investig."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1093\/infdis\/167.2.270","article-title":"Circulating cytomegalovirus (CMV)-infected endothelial cells in patients with an active CMV infection","volume":"167","author":"Grefte","year":"1993","journal-title":"J. Infect. Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1093\/infdis\/168.5.1110","article-title":"Ultrastructural analysis of circulating cytomegalic cells in patients with active cytomegalovirus infection: Evidence for virus production and endothelial origin","volume":"168","author":"Grefte","year":"1993","journal-title":"J. Infect. Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1093\/infdis\/166.6.1236","article-title":"Human cytomegalovirus infection of the major leukocyte subpopulations and evidence for initial viral replication in polymorphonuclear leukocytes from viremic patients","volume":"166","author":"Gerna","year":"1992","journal-title":"J. Infect. Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"5629","DOI":"10.1128\/JVI.74.12.5629-5638.2000","article-title":"Human cytomegalovirus replicates abortively in polymorphonuclear leukocytes after transfer from infected endothelial cells via transient microfusion events","volume":"74","author":"Gerna","year":"2000","journal-title":"J. Virol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1099\/jgv.0.000882","article-title":"The pentameric complex of human cytomegalovirus: Cell tropism, virus dissemination, immune response and vaccine development","volume":"98","author":"Gerna","year":"2017","journal-title":"J. Gen. Virol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/rmv.645","article-title":"Human cytomegalovirus tropism for endothelial\/epithelial cells: Scientific background and clinical implications","volume":"20","author":"Revello","year":"2010","journal-title":"Rev. Med. Virol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/jmv.1890250208","article-title":"Rapid immunodiagnosis of active cytomegalovirus infection by monoclonal antibody staining of blood leukocytes","volume":"25","author":"Torensma","year":"1988","journal-title":"J. Med. Virol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/jmv.1890290204","article-title":"Detection of human cytomegalovirus immediate-early antigen in leukocytes as a marker of viremia in immunocompromised patients","volume":"29","author":"Revello","year":"1989","journal-title":"J. Med. Virol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1099\/0022-1317-73-2-437","article-title":"Nuclear expression of the lower matrix protein of human cytomegalovirus in peripheral blood leukocytes of immunocompromised viremic patients","volume":"73","author":"Revello","year":"1992","journal-title":"J. Gen. Virol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1128\/jcm.19.6.917-919.1984","article-title":"Rapid detection of cytomegalovirus in MRC-5 cells inoculated with urine specimens by using low-speed centrifugation and monoclonal antibody to an early antigen","volume":"19","author":"Gleaves","year":"1984","journal-title":"J. Clin. Microbiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1128\/jcm.28.12.2681-2688.1990","article-title":"Quantification of human cytomegalovirus viremia by using monoclonal antibodies to different viral proteins","volume":"28","author":"Gerna","year":"1990","journal-title":"J. Clin. Microbiol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1093\/infdis\/164.3.488","article-title":"Monitoring of human cytomegalovirus infections and ganciclovir treatment in heart transplant recipients by determination of viremia, antigenemia and DNAemia","volume":"164","author":"Gerna","year":"1991","journal-title":"J. Infect. Dis."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1128\/jcm.32.11.2709-2717.1994","article-title":"Comparative quantitation of human cytomegalovirus DNA in blood leukocytes and plasma of transplant and AIDS patients","volume":"32","author":"Gerna","year":"1994","journal-title":"J. Clin. Microbiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1097\/00007890-199805270-00016","article-title":"Human cytomegalovirus (HCMV) leukoDNAemia correlates more closely with clinical symptoms than antigenemia and viremia in heart and heart-lung transplant recipients with primary HCMV infection","volume":"65","author":"Gerna","year":"1998","journal-title":"Transplantation"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1097\/01.TP.0000057239.32192.B9","article-title":"Human cytomegalovirus pp67 mRNAemia vs pp65 antigenemia in heart and lung transplant recipients: A prospective randomized controlled open-label trial","volume":"75","author":"Gerna","year":"2003","journal-title":"Transplantation"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"5053","DOI":"10.1182\/blood-2002-12-3636","article-title":"Human cytomegalovirus immediate early mRNAemia versus pp65 antigenemia for guiding preemptive therapy in children and young adults undergoing hematopoietic stem cell transplantation: A prospective, randomized, open-label trial","volume":"101","author":"Gerna","year":"2003","journal-title":"Blood"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/infdis\/171.2.263","article-title":"Bidirectional transmission of infectious cytomegalovirus between monocytes and vascular endothelial cells: An in vitro model","volume":"171","author":"Waldman","year":"1995","journal-title":"J. Infect. Dis."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/BF01310761","article-title":"Preservation of natural endothelial cytopathogenicity of cytomegalovirus by propagation in endothelial cells","volume":"117","author":"Waldman","year":"1991","journal-title":"Arch. Virol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1172\/JCI1633","article-title":"In vitro generation of human cytomegalovirus pp65 antigenemia, viremia, and leukoDNAemia","volume":"101","author":"Revello","year":"1998","journal-title":"J. Clin. Investig."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1086\/515300","article-title":"Cytomegalovirus-infected endothelial cells recruit neutrophil by the secretion of C-X-C chemokines and transmit virus by direct neutrophil-endothelial cell contact and during neutrophil transendothelial migration","volume":"177","author":"Grundy","year":"1998","journal-title":"J. Infect. Dis."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/jmv.2208","article-title":"Human cytomegalovirus as a direct pathogen: Correlation of multiorgan involvement and cell distribution with clinical and pathological findings in a case of congenital inclusion disease","volume":"67","author":"Bissinger","year":"2002","journal-title":"J. Med. Virol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1099\/0022-1317-77-1-61","article-title":"Role of apical and basolateral membranes in replication of human cytomegalovirus in polarized retinal pigment epithelial cells","volume":"77","author":"Tugizov","year":"1996","journal-title":"J. Gen. Virol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/00007890-198809000-00019","article-title":"Human cytomegalovirus infection of kidney glomerular visceral epithelial and tubular epithelial cells in culture","volume":"46","author":"Heieren","year":"1988","journal-title":"Transplantation"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1086\/315032","article-title":"Hepatocytes are permissive for human cytomegalovirus infection in human liver cell culture and in vivo","volume":"180","author":"Sinzger","year":"1999","journal-title":"J. Infect. Dis."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1099\/0022-1317-82-6-1429","article-title":"In vitro selection of human cytomegalovirus variants unable to transfer virus and virus products from infected cells to polymorphonuclear leukocytes and to grow in endothelial cells","volume":"82","author":"Revello","year":"2001","journal-title":"J. Gen. Virol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/jmv.2150","article-title":"Lack of transmission to polymorphonuclear leukocytes and human umbilical vein endothelial cells as a marker of attenuation of human cytomegalovirus","volume":"66","author":"Gerna","year":"2002","journal-title":"J. Med. Virol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1099\/0022-1317-83-8-1993","article-title":"The attenuated Towne strain of human cytomegalovirus may revert to both endothelial cell tropism and leuko-(neutrophil and monocyte-) tropism in vitro","volume":"83","author":"Gerna","year":"2002","journal-title":"J. Gen. Virol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1099\/vir.0.19055-0","article-title":"Rescue of human cytomegalovirus strain AD169 tropism for both leukocytes and human endothelial cells","volume":"84","author":"Gerna","year":"2003","journal-title":"J. Gen. Virol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/jmv.10262","article-title":"Genomes of endothelial cell-tropic variant and the parental Toledo strain of human cytomegalovirus are highly divergent","volume":"69","author":"Baldanti","year":"2003","journal-title":"J. Med. Virol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"14759","DOI":"10.1073\/pnas.94.26.14759","article-title":"Cloning and mutagenesis of a herpesvirus genome as an infectious bacterial artificial chromosome","volume":"94","author":"Messerle","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"9551","DOI":"10.1128\/JVI.76.18.9551-9555.2002","article-title":"The human cytomegalovirus ribonucleotide reductase homolog UL45 is dispensable for growth in endothelial cells, as determined by a BAC-cloned clinical isolate of human cytomegalovirus with preserved wild type characteristics","volume":"76","author":"Hahn","year":"2002","journal-title":"J. Virol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1099\/vir.0.013250-0","article-title":"High-throughput sequence analysis of variants of human cytomegalovirus strains Towne and AD169","volume":"90","author":"Bradley","year":"2009","journal-title":"J. Gen. Virol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1128\/jvi.70.1.78-83.1996","article-title":"Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains","volume":"70","author":"Cha","year":"1996","journal-title":"J. Virol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/rmv.315","article-title":"A review of genetic differences between limited and extensively passaged human cytomegalovirus strains","volume":"11","author":"Prichard","year":"2001","journal-title":"Rev. Med. Virol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"10023","DOI":"10.1128\/JVI.78.18.10023-10033.2004","article-title":"Human cytomegalovirus UL131-128 genes are indispensable for virus growth in endothelial cells and virus transfer to leukocytes","volume":"78","author":"Hahn","year":"2004","journal-title":"J. Virol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"10330","DOI":"10.1128\/JVI.79.16.10330-10338.2005","article-title":"Human cytomegalovirus UL131 open reading frame is required for epithelial cell tropism","volume":"79","author":"Wang","year":"2005","journal-title":"J. Virol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"18153","DOI":"10.1073\/pnas.0509201102","article-title":"Human cytomegalovirus virion protein complex required for epithelial and endothelial cell tropism","volume":"102","author":"Wang","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"7825","DOI":"10.1128\/JVI.00445-07","article-title":"Epstein-Barr virus entry","volume":"81","year":"2007","journal-title":"J. Virol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"7969","DOI":"10.1128\/JVI.78.15.7969-7983.2004","article-title":"Intracellular processing of human herpesvirus 6 glycoproteins Q1 and Q2 into tetrameric complexes expressed on the viral envelope","volume":"78","author":"Akkapaiboon","year":"2004","journal-title":"J. Virol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1128\/JVI.80.2.710-722.2006","article-title":"Human cytomegalovirus entry into epithelial and endothelial cells depends on genes UL128 to UL150 and occurs by endocytosis and low-pH fusion","volume":"80","author":"Ryckman","year":"2006","journal-title":"J. Virol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1128\/JVI.01910-07","article-title":"Characterization of human cytomegalovirus gH\/gL\/UL128-131 complex that mediates entry into epithelial and endothelial cells","volume":"82","author":"Ryckman","year":"2008","journal-title":"J. Virol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1007\/s00705-005-0696-5","article-title":"Human cytomegalovirus UL131A, UL130 and UL128 genes are highly conserved among field isolates","volume":"151","author":"Baldanti","year":"2006","journal-title":"Arch. Virol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"14118","DOI":"10.1073\/pnas.0804365105","article-title":"HCMV gH\/gL\/UL128-131 interferes with virus entry into epithelial cells: Evidence for cell type-specific receptors","volume":"105","author":"Ryckman","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"8191","DOI":"10.1128\/JVI.72.10.8191-8197.1998","article-title":"The human cytomegalovirus UL74 gene encodes the third component of the glycoprotein H-glycoprotein L-containing envelope complex","volume":"72","author":"Huber","year":"1998","journal-title":"J. Virol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1016\/S1386-6532(02)00098-7","article-title":"Expression and reconstitution of the gH\/gL\/gO complex of human cytomegalovirus","volume":"25","author":"Kinzler","year":"2002","journal-title":"J. Clin. Virol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"15470","DOI":"10.1073\/pnas.0406821101","article-title":"Cellular integrins function as entry receptors for human cytomegalovirus via a highly conserved disintegrin-like domain","volume":"101","author":"Feire","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/tra.12355","article-title":"HCMV induces macropinocytosis for host cell entry in fibroblasts","volume":"17","author":"Hetzenecker","year":"2016","journal-title":"Traffic"},{"key":"ref_55","unstructured":"Tang, J., Ostermann, E., Lebbink, R.J., and Brune, W. (2019, January 7\u201311). Human cytomegalovirus glycoprotein B variants affect viral entry, cell fusion, and genome stability. Proceedings of the 7th International Congenital CMV Conference and 17th International CMV Workshop (CMV 2019 Abstracts), Birmingham, AL, USA. Abstract 5.04."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1099\/vir.0.83523-0","article-title":"Human cytomegalovirus serum neutralizing antibodies block virus infection of endothelial\/epithelial cells, but not fibroblasts, early during primary infection","volume":"89","author":"Gerna","year":"2008","journal-title":"J. Gen. Virol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1099\/vir.0.81921-0","article-title":"Role of human cytomegalovirus UL131A in cell type-specific virus entry and release","volume":"87","author":"Adler","year":"2006","journal-title":"J. Gen. Virol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"5760","DOI":"10.1016\/j.vaccine.2008.07.092","article-title":"Cytomegalovirus vaccines fail to induce epithelial entry neutralizing antibodies comparable to natural infection","volume":"26","author":"Cui","year":"2008","journal-title":"Vaccine"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1128\/JVI.01809-09","article-title":"Isolation of human monoclonal antibodies that potently neutralize human cytomegalovirus infection by targeting different epitopes on the gH\/gL\/UL128-131A complex","volume":"84","author":"Macagno","year":"2010","journal-title":"J. Virol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"7444","DOI":"10.1128\/JVI.00467-12","article-title":"Antibodies against the gH\/gL\/UL128\/UL130\/UL131 complex comprise the majority of the anti-cytomegalovirus (anti-CMV) neutralizing antibody response in CMV hyperimmune globulin","volume":"86","author":"Fouts","year":"2012","journal-title":"J. Virol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"E4997","DOI":"10.1073\/pnas.1316517110","article-title":"Pentameric complex of viral glycoprotein H is the primary target for potent neutralization by a human cytomegalovirus vaccine","volume":"110","author":"Freed","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1073\/pnas.1424818112","article-title":"Structural and biochemical studies of HCMV gH\/gL\/gO and pentamer reveal mutually exclusive cell entry complexes","volume":"112","author":"Ciferri","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"4471","DOI":"10.1073\/pnas.1419875112","article-title":"A viral regulator of glycoprotein complexes contributes to human cytomegalovirus cell tropism","volume":"112","author":"Li","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Ciferri, C., Chandramouli, S., Leitner, A., Donnarumma, D., Cianfrocco, M.A., Gerrein, R., Friedrich, K., Aggarwal, Y., Palladino, G., and Aebersold, R. (2015). Antigenic characterization of the HCMV gH\/gL\/gO and pentamer entry complexes reveals binding sites for potently neutralizing human antibodies. PLoS Pathog., 11.","DOI":"10.1371\/journal.ppat.1005230"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1128\/JVI.02249-09","article-title":"A human cytomegalovirus gO-null mutant fails to incorporate gH\/gL into the virion envelope and is unable to enter fibroblasts and epithelial and endothelial cells","volume":"84","author":"Wille","year":"2010","journal-title":"J. Virol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"e00332-13","DOI":"10.1128\/mBio.00332-13","article-title":"Human cytomegalovirus (HCMV) glycoprotein B promotes virus entry in trans acting as the viral fusion protein rather than as a receptor-binding protein","volume":"4","author":"Wille","year":"2013","journal-title":"mBio"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"8999","DOI":"10.1128\/JVI.01325-15","article-title":"Human cytomegalovirus gH\/gL\/gO promotes the fusion step of entry into all cell types whereas gH\/gL\/UL128-131 broadens virus tropism through a distinct mechanism","volume":"89","author":"Zhou","year":"2015","journal-title":"J. Virol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"16082","DOI":"10.1038\/nmicrobiol.2016.82","article-title":"Platelet-derived growth factor-\u03b1 receptor for human cytomegalovirus gHgLgO trimer","volume":"1","author":"Kabanova","year":"2016","journal-title":"Nat. Microbiol."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Vanarsdall, A.L., Howard, P.W., Wisner, T.W., and Johnson, D.C. (2016). Human cytomegalovirus gH\/gL forms a stable complex with the fusion protein gB in virions. PLoS Pathog., 12.","DOI":"10.1371\/journal.ppat.1005564"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/nature07209","article-title":"Platelet-derived growth factor-alpha receptor activation is required for human cytomegalovirus infection","volume":"455","author":"Soroceanu","year":"2008","journal-title":"Nature"},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Wu, Y., Prager, A., Boos, S., Resch, M., Brizic, I., Mach, M., Wildner, S., Scrivano, L., and Adler, B. (2017). Human cytomegalovirus glycoprotein complex gH\/gL\/gO uses PDGFR-\u03b1 as a key for entry. PLoS Pathog., 13.","DOI":"10.1371\/journal.ppat.1006281"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.cell.2018.06.028","article-title":"An unbiased screen for human cytomegalovirus identifies neuropilin-2 as a central viral receptor","volume":"174","author":"Marcandalli","year":"2018","journal-title":"Cell"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/0042-6822(92)90200-9","article-title":"Human cytomegalovirus penetrates host cells by pH-independent fusion at the cell surface","volume":"191","author":"Compton","year":"1992","journal-title":"Virology"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"20037","DOI":"10.1073\/pnas.0709704104","article-title":"Human cytomegalovirus uses two distinct pathways to enter retinal pigmented epithelial cells","volume":"104","author":"Wang","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"7043","DOI":"10.1073\/pnas.1814850116","article-title":"OR14I1 is a receptor for the human cytomegalovirus pentameric complex and defines viral epithelial cell tropism","volume":"116","author":"E","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"e01336-18","DOI":"10.1128\/JVI.01336-18","article-title":"The human cytomegalovirus trimer and pentamer promote sequential steps in entry into epithelial and endothelial cells at cell surfaces and endosomes","volume":"92","author":"Liu","year":"2018","journal-title":"J. Virol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.coviro.2018.05.004","article-title":"From recognition to execution- The HCMV pentamer from receptor binding to fusion triggering","volume":"31","author":"Malito","year":"2018","journal-title":"Curr. Opin. Virol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1128\/JVI.01875-15","article-title":"Scanning mutagenesis of human cytomegalovirus glycoprotein gH\/gL","volume":"90","author":"Schultz","year":"2016","journal-title":"J. Virol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"e01255-17","DOI":"10.1128\/JVI.01255-17","article-title":"Epstein-Barr virus fusion with epithelial cells triggered by gB is restricted by a gL glycosilation site","volume":"91","author":"Mohl","year":"2017","journal-title":"J. Virol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"e01794-16","DOI":"10.1128\/AAC.01794-16","article-title":"Phase 2 randomized, double-blind, placebo-controlled trial of RG7667, a combination monoclonal antibody, for prevention of cytomegalovirus infection in high-risk kidney transplant recipients. Antimicrob","volume":"61","author":"Ishida","year":"2017","journal-title":"Agents Chemother."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"362ra145","DOI":"10.1126\/scitranslmed.aaf9387","article-title":"A replication-defective human cytomegalovirus vaccine for prevention of congenital infection","volume":"8","author":"Wang","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"17965","DOI":"10.1073\/pnas.1415310111","article-title":"Antibody-driven vaccine design: A human cytomegalovirus gHgLpUL128L subunit vaccine selectively eliciting potent neutralizing antibodies","volume":"111","author":"Kabanova","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"e01012-18","DOI":"10.1128\/JVI.01012-18","article-title":"Multiantigenic modified vaccinia virus ankara vaccine vectors to elicit potent humoral and cellular immune reponses against human cytomegalovirus in mice","volume":"92","author":"Chiuppesi","year":"2018","journal-title":"J. Virol."}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/7\/3\/70\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:08:26Z","timestamp":1760188106000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/7\/3\/70"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,22]]},"references-count":83,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2019,9]]}},"alternative-id":["vaccines7030070"],"URL":"https:\/\/doi.org\/10.3390\/vaccines7030070","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,22]]}}}